Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Followship at University of Zakho, United Kingdom

Dr. Khalid Subhi Ibrahim, an Assistant Professor at the University of Zakho, is a distinguished researcher in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. With a Ph.D. from Glasgow Caledonian University, his work focuses on understanding gut bacterial communities in obesity, Type 2 diabetes, and other health conditions using cutting-edge techniques like next-generation sequencing and bioinformatics tools such as QIIME2 and PICRUSt2. He has led significant collaborations, including projects with the Massachusetts Institute of Technology (MIT) and Kiel University, Germany, and has contributed to global microbiome conservancy efforts. An Editor-in-Chief of SJUOZ and a committee member of MVIF, Dr. Ibrahim’s expertise extends to training scientists, publishing research, and presenting at international conferences. His diverse contributions reflect his commitment to advancing microbiome research and its applications in health and environmental sciences.

Professional Profile

Education

Dr. Khalid Subhi Ibrahim holds a Ph.D. in Life Sciences from Glasgow Caledonian University, UK (2013-2017), where his research focused on “Biochemical Interactions Between the Gut Microbiome and Host in Obesity/Type 2 Diabetes.” He also completed an MSc in Veterinary Pathology specializing in fish diseases at the University of Duhok, Kurdistan Region, Iraq (2006-2008), presenting a thesis on pathological studies in common carp infected with Aeromonas hydrophila. Dr. Khalid earned his Bachelor of Veterinary Medicine (Medicine and Surgery) from the same institution in 2004. Additionally, he attended a Pre-sessional English Language program at Glasgow University in 2012. Throughout his education, Dr. Khalid developed extensive expertise in microbiology, molecular diagnostics, and bioinformatics. His academic foundation reflects a robust combination of veterinary science, microbiological research, and advanced molecular techniques, forming the basis of his prolific career in microbiome studies and biomedical sciences.

Professional Experience

Dr. Khalid Subhi Ibrahim is an accomplished Assistant Professor with extensive experience in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and gut microbiome research. He has a strong background in utilizing advanced molecular techniques such as next-generation sequencing, bioinformatics, and 16S rRNA analysis to explore microbiota in various contexts, including obesity, Type 2 diabetes, pollution, and animal health. Dr. Ibrahim has collaborated with prestigious institutions such as Glasgow Caledonian University, Monash University, MIT, and Universitätsklinikum Schleswig-Holstein on numerous international projects. His expertise extends to training scientists, supervising research students, and contributing to impactful research. Additionally, he has served as Editor-in-Chief of the SJUOZ journal and actively participated in global microbiome conservancy initiatives. With a proven track record of research, teaching, and collaboration, Dr. Ibrahim is dedicated to advancing microbiome science and fostering academic excellence.

Research Interest

Dr. Khalid Subhi Ibrahim’s research interests focus on biomedical sciences, with expertise in diagnostic and molecular microbiology, clinical biochemistry, and bioinformatics. His work centers on understanding the role of gut microbiome changes in health and disease, particularly in obesity, Type 2 diabetes mellitus (T2DM), and pollution. Employing advanced molecular techniques and next-generation sequencing, he investigates microbiota in humans, animals, soils, and wastewater, emphasizing 16S rRNA analysis using tools like QIIME2 and PICRUSt2. Dr. Ibrahim’s research extends to metagenomics and functional analysis of microbiomes in various contexts, including colorectal cancer, nosocomial infections in children, and zoonotic diseases in livestock. His collaborations span globally, engaging with institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and the University of Tartu. Driven by a passion for microbiome research, he aims to advance in silico analysis techniques, enriching the understanding of microbial ecosystems and their impacts on human and environmental health.

Award and Honor

Dr. Khalid Subhi Ibrahim, a distinguished microbiologist and academic, has earned recognition for his remarkable contributions to biomedical sciences, particularly in microbiome research. Serving as Assistant Professor at the University of Zakho, Dr. Ibrahim leads the Global Microbiome Conservancy in Iraq and holds the prestigious position of Editor-in-Chief for the Scientific Journal of University of Zakho (SJUOZ). His collaborative endeavors span globally, involving partnerships with renowned institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and Monash University. Dr. Ibrahim’s accolades include delivering impactful presentations at international conferences and publishing high-impact research on gut microbiota’s role in obesity, Type 2 diabetes, and pollution. His expertise in bioinformatics and next-generation sequencing has advanced the understanding of microbial communities in diverse ecosystems. Committed to mentorship and innovation, Dr. Ibrahim’s career reflects a dedication to advancing scientific knowledge and fostering international collaboration in microbiome science.

Conclusion

Dr. Khalid Subhi Ibrahim is a distinguished researcher with expertise in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. His extensive academic and professional journey reflects a strong commitment to advancing biomedical sciences, with a particular focus on gut microbiome research in relation to obesity, Type 2 diabetes, pollution, and colorectal cancer. Dr. Ibrahim’s collaborative projects with esteemed institutions, including MIT and the University of Tartu, underscore his global impact and research network. His proficiency in cutting-edge techniques such as next-generation sequencing, bioinformatics, and microbiota analysis highlights his technical expertise. Additionally, his dedication to knowledge dissemination through teaching, supervising, and publishing further solidifies his contributions to science. While Dr. Ibrahim’s focus on microbiome studies is commendable, expanding his publication record in high-impact journals would further strengthen his academic influence. Overall, Dr. Khalid Subhi Ibrahim demonstrates exceptional merit as a candidate for the Best Researcher Award.

Publications Top Noted

  1. Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    Authors: Naghavi, M., Ong, K.L., Aali, A., Wool, E.E., Murray, C.J.L.
    Year: 2024
    Citations: 259
  2. Title: Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq
    Authors: Ibrahim, D.R., Saadi, A.T., Yahya, N.B., Alarsalani, B.K., Ibrahim, K.S.
    Year: 2024
    Citations: 0
  3. Title: Global Burden of Cardiovascular Diseases and Risks, 1990-2022
    Authors: Mensah, G.A., Habtegiorgis Abate, Y., Abbasian, M., Murray, C.J.L., Roth, G.A.
    Year: 2023
    Citations: 295
  4. Title: Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration
    Authors: Cao, Y., Ibrahim, K.S., Li, X., Craft, J.A., Shu, X.
    Year: 2023
    Citations: 0
  5. Title: Molecular Characterization of Extended Spectrum β-Lactamase (ESBL) and Virulence Gene-Factors in Uropathogenic Escherichia coli (UPEC) in Children in Duhok City, Kurdistan Region, Iraq
    Authors: Hasan, S.M., Ibrahim, K.S.
    Year: 2022
    Citations: 5
  6. Title: In silico analysis of bacterial metabolism of glutamate and GABA in the gut in a rat model of obesity and type 2 diabetes
    Authors: Ibrahim, K.S., Bourwis, N., Dolan, S., Craft, J.A.
    Year: 2022
    Citations: 2
  7. Title: Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration
    Authors: Biswas, L., Ibrahim, K.S., Li, X., Craft, J., Shu, X.
    Year: 2021
    Citations: 16
  8. Title: Transcriptome-wide changes associated with the reproductive behaviour of male guppies exposed to 17α-ethinyl estradiol
    Authors: Saaristo, M., Craft, J.A., Tyagi, S., Ibrahim, K.S., Wong, B.B.M.
    Year: 2021
    Citations: 8
  9. Title: Prevalence and Hemato-biochemical Studies on Theileriosis in Naturally Infected Cattle in Erbil Province
    Authors: Aziz, K., Qader, N., Ibrahim, K.
    Year: 2021
    Citations: 3
  10. Title: Etifoxine reverses weight gain and alters the colonic bacterial community in a mouse model of obesity
    Authors: Ibrahim, K.S., Craft, J.A., Biswas, L., Spencer, J., Shu, X.
    Year: 2020
    Citations: 15

 

 

Paul Cullen | Genetics | Best Researcher Award

Dr. Paul Cullen | Genetics | Best Researcher Award

Doctorate at University at Buffalo, United States

Dr. Paul Cullen is a Professor in the Department of Biological Sciences at the University at Buffalo, specializing in molecular genetics and cell biology. He completed his postdoctoral training at the Institute of Molecular Biology at the University of Oregon, where he worked on MAP kinase (MAPK) signaling pathways, funded by grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Cullen earned his Ph.D. in Molecular Genetics from Washington University in Saint Louis, where his research focused on bacterial nitrogen control proteins. He holds a Bachelor of Science in Biological Sciences from the University of Illinois at Urbana-Champaign, graduating Magna Cum Laude with Distinction. Dr. Cullen’s research interests revolve around understanding the regulation of cellular differentiation and signaling pathways, particularly in yeast. He has received numerous accolades, including the UB Exceptional Scholar’s Award and the Distinguished Postdoc Mentor Award. His work is supported by multiple NIH grants, and he has contributed significantly to the scientific community through publications and mentorship.

Education

Dr. Paul Cullen holds an impressive educational background in the field of biological sciences and molecular genetics. He earned his Bachelor of Science degree in Biological Sciences from the University of Illinois, Urbana-Champaign, graduating Magna Cum Laude with Distinction in 1990. His undergraduate thesis, titled “Effect of Ecdysone on In Vitro Pupal Wing Development in Lepidoptera,” was conducted under the supervision of Dr. Judith Willis and Dr. Johnathan Widom. Following this, Dr. Cullen pursued his Doctor of Philosophy (Ph.D.) in Molecular Genetics at Washington University, Saint Louis, completing his degree in 1997. His Ph.D. research, titled “Bacterial Nitrogen Control Proteins,” was guided by Dr. Robert G. Kranz. Additionally, from 1998 to 2004, Dr. Cullen completed postdoctoral training at the Institute of Molecular Biology at the University of Oregon, under the mentorship of Dr. George F. Sprague, Jr. His postdoctoral work was supported by prestigious grants from the American Heart Association and the National Institutes of Health (NIH), further solidifying his expertise in molecular biology.

Professional Experience

Dr. Paul Cullen has held a series of prestigious academic and research positions throughout his career. He is currently a Professor in the Department of Biological Sciences at the University at Buffalo, where he has been a faculty member since 2004. Prior to his promotion to Professor in 2017, Dr. Cullen served as an Associate Professor from 2010 to 2017 and as an Assistant Professor from 2004 to 2010. He has also held a joint appointment as Clinical Research Assistant Professor in the Department of Microbiology and Immunology since 2005. Earlier in his career, Dr. Cullen was a Senior Research Fellow at the Institute of Molecular Biology at the University of Oregon from 2000 to 2004. He has also contributed to scientific review panels, including serving as an NIH Review Panelist for Eukaryotic Pathogens in 2024. In addition to his research, Dr. Cullen has been deeply involved in academic administration, serving as the Director of Graduate Affairs for the Department of Biological Sciences from 2019 to 2024 and as a member of the Graduate School Executive Committee from 2023 to 2024.

Research Interest

Dr. Paul Cullen’s research interests focus on understanding the molecular mechanisms that regulate cellular differentiation, particularly through MAP kinase (MAPK) signaling pathways. His work explores how these pathways control cellular responses to environmental cues, with a special emphasis on the filamentous growth of Saccharomyces cerevisiae (yeast). Dr. Cullen investigates the role of cell polarity proteins in modulating MAPK signaling and how regulatory proteins influence these pathways. His research also extends to studying signal transduction in various biological systems, aiming to uncover broader implications for cellular behavior and development in eukaryotic organisms. Through his work, Dr. Cullen seeks to advance knowledge of genetic and molecular processes that underpin complex biological responses, contributing to the fields of molecular genetics, cell biology, and microbiology.

Research Skills

Dr. Paul Cullen possesses extensive research skills in molecular genetics and cell biology, particularly in the regulation of MAP kinase (MAPK) signaling pathways. His expertise includes advanced molecular techniques such as gene manipulation, protein-protein interaction studies, and genetic screening in model organisms like Saccharomyces cerevisiae. Dr. Cullen is skilled in using molecular and genetic tools to investigate cellular differentiation, signal transduction, and environmental response mechanisms. He has a strong background in high-throughput screening, microscopy, and quantitative data analysis. His research also involves cutting-edge technologies in genetic sequencing, bioinformatics, and structural biology, contributing to his deep understanding of cellular signaling networks and their implications for health and disease.

Award and Recognition

Dr. Paul Cullen has received numerous accolades for his exemplary contributions to research and education. In 2023, he was honored with the UB Exceptional Scholar’s Award for Sustained Achievement and the UB Graduate School Distinguished Postdoc Mentor Award, recognizing his significant impact in mentorship. Additionally, he received the Milton Plesur Excellence in Teaching Award in 2008 for his dedication to student learning. His active membership in professional organizations such as the American Society of Cell Biology and the American Society of Microbiology further highlights his commitment to advancing the field of molecular biology.

Conclusion

Dr. Paul Cullen’s remarkable achievements in molecular biology, sustained research contributions, and commitment to mentoring make him a distinguished figure in his field. His combination of academic excellence, leadership, and impactful research positions him as an exemplary candidate for the “Research for Best Researcher Award.”

Publication Top Notes

  • “Glucose depletion causes haploid invasive growth in yeast”
    • Journal: Proceedings of the National Academy of Sciences
    • Cited by: 444
    • Year: 2000
    • Volume: 97, Issue 25
    • Pages: 13619-13624
  • “The regulation of filamentous growth in yeast”
    • Journal: Genetics
    • Cited by: 348
    • Year: 2012
    • Volume: 190, Issue 1
    • Pages: 23-49
  • “A signaling mucin at the head of the Cdc42-and MAPK-dependent filamentous growth pathway in yeast”
    • Journal: Genes & Development
    • Cited by: 268
    • Year: 2004
    • Volume: 18, Issue 14
    • Pages: 1695-1708
  • “GTPase-activating proteins for Cdc42”
    • Journal: Eukaryotic Cell
    • Cited by: 170
    • Year: 2002
    • Volume: 1, Issue 3
    • Pages: 469-480
  • “Defects in Protein Glycosylation Cause SHO1-Dependent Activation of a STE12 Signaling Pathway in Yeast”
    • Journal: Genetics
    • Cited by: 147
    • Year: 2000
    • Volume: 155, Issue 3
    • Pages: 1005-1018
  • “Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast”
    • Journal: The Journal of Cell Biology
    • Cited by: 144
    • Year: 2008
    • Volume: 181, Issue 7
    • Pages: 1073-1081
  • “Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis”
    • Journal: PLoS One
    • Cited by: 112
    • Year: 2012
    • Volume: 7, Issue 11
    • Pages: e46020
  • “Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins”
    • Journal: NPJ Biofilms and Microbiomes
    • Cited by: 111
    • Year: 2019
    • Volume: 5, Issue 1
    • Pages: 21